• Aerospace
  • Agriculture
  • Consumer Services
  • Healthcare
  • Energy And Resources
  • Food & Beverages
  • Electric Equipments
  • Materials And Chemicals
  • Semiconductor
  • Technology And Media
  • Transportation And Shipping
  • Automobile & Transportation
  • Chemical & Material
  • Medical Devices
  • Banking
  • Drugs By Therapeutics Area
  • Oncology Drugs
  • Therapeutics Area
  • Healthcare services
  • Diagnostics
  • Laboratory Equipment
  • Metals And Minerals
  • Rubber
  • Consumer Electronics
  • Personal care products
  • Travel And Tourism
  • Energy & Power
  • Computing And Technology
  • Electronics
  • Food Ingredients
  • Military
  • Defense
  • Machinery & Equipment
  • Heavy Industries
  • Industrial Automation
  • Asia Pacific
  • Pharmaceutical
  • NanoTechnology
  • Vaccines
  • Consumer Goods
  • Others
  • Service & Software
Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor

Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor

Date: Jan-2019 | Id: MACRC-0995 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs...

H 4 Antagonist

H 4 Antagonist

Date: Jan-2019 | Id: MACRC-0988 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “H 4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objectiv...

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor

Date: Jan-2019 | Id: MACRC-0955 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this me...

D4 Antagonist

D4 Antagonist

Date: Jan-2019 | Id: MACRC-0935 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “D4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objective...

D4 Agonist

D4 Agonist

Date: Jan-2019 | Id: MACRC-0934 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “D4 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objective of...

Cytochrome P450 17 (CYP17) Inhibitor

Cytochrome P450 17 (CYP17) Inhibitor

Date: Jan-2019 | Id: MACRC-0926 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Cytochrome P450 17 (CYP17) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action...

Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor

Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor

Date: Jan-2019 | Id: MACRC-0925 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Cytochrome P450 Superfamily (CYP or CYP450) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this me...

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor

Date: Jan-2019 | Id: MACRC-0920 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism...

CXCR4 Inhibitor

CXCR4 Inhibitor

Date: Jan-2019 | Id: MACRC-0916 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “CXCR4 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objecti...

CD40 Agonist

CD40 Agonist

Date: Jan-2019 | Id: MACRC-0903 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “CD40 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objective ...